STIP1 polypeptides and uses thereof
The present invention is directed toward pharmaceutical compositions comprising an isolated polypeptide and a pharmaceutically acceptable carrier. The present invention also discloses an antibody or an antigen-binding portion thereof that bind to the isolated polypeptide. Methods of inhibiting cancer cells growth are also disclosed, comprising administering the isolated polypeptide or the antibody described herein to a subject in need thereof.
1. A pharmaceutical composition, comprising an isolated polypeptide comprising an amino acid sequence at least 90% homologous to SEQ ID NO:1; a pharmaceutically acceptable carrier; and an antibody against STIP1.
2. An antibody, or an antigen-binding portion thereof, binding to an amino acid sequence at least 90% homologous to SEQ ID NO:1.
3. A pharmaceutical composition, comprising
an antibody, or an antigen-binding portion thereof, binding to an amino acid sequence at least 90% homologous to SEQ ID NO:1; and
a pharmaceutically acceptable carrier.
4. The pharmaceutical composition of claim 3 , further comprising an isolated polypeptide comprising an amino acid sequence at least 90% homologous to SEQ ID NO:1.